Metachronous Bilateral Renal Cell Carcinoma: Risk Assessment, Prognosis and Relevance of the Primary-Free Interval

Author:

Klatte Tobias1,Patard Jean-Jacques2,Wunderlich Heiko3,Goel Rakhee H.1,Lam John S.1,Junker Kerstin3,Schubert Jörg3,Böhm Malte4,Allhoff Ernst P.4,Kabbinavar Fairooz F.5,Crepel Maxime2,Cindolo Luca6,De La Taille Alexandre7,Tostain Jacques8,Mejean Arnaud9,Soulie Michel10,Bellec Laurent10,Bernhard Jean Christophe11,Ferriere Jean-Marie11,Pfister Christian12,Albouy Baptiste12,Colombel Marc13,Zisman Amnon14,Belldegrun Arie S.1,Pantuck Allan J.1

Affiliation:

1. Department of Urology, University of California-Los Angeles, Los Angeles, California

2. Departments of Urology, University of Rennes, Rennes, France

3. University of Jena, Jena, Germany

4. University of Magdeburg, Magdeburg, Germany

5. Department of Medicine, University of California-Los Angeles, Los Angeles, California

6. Università del Sannio, Benevento, Italy

7. Centre Hospitalier Universitaire Henri Mondor, Creteil, France

8. University of Saint-Etienne, Saint-Etienne, France

9. Necker Hospital, Paris, France

10. University of Toulouse, Toulouse, France

11. University of Bordeaux, Bordeaux, France

12. University of Rouen, Rouen, France

13. University of Lyon, Lyon, France

14. Tel-Aviv University, Tel-Aviv, Israel

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3